Identifying molecular targets mediating the anticancer activity of histone deacetylase inhibitors: a work in progress

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Anticancer properties of histone deacetylase inhibitors (HDACis) are established.
• Intracellular targets mediating these effects are increasingly being identified.

Purpose of the Study:

• To review the progress in identifying molecular pathways and events responsible for the anticancer activity of HDACis.
• To highlight the importance of understanding target identities for rational cancer therapy design.

Main Methods:

• Literature review of recent research on HDAC inhibitors and their molecular targets.
• Analysis of studies focusing on cell cycle control, apoptosis, and differentiation pathways.
• Examination of the role of histone and non-histone protein acetylation.

Main Results:

• HDACis modulate key cellular processes including cell cycle control, apoptosis, and differentiation.
• Alterations in acetylation status of histone and non-histone targets are critical for HDACi efficacy.
• Specific HDAC enzymes and their targets are being elucidated.

Conclusions:

• Identifying molecular targets and specific HDAC enzymes is essential for developing targeted cancer therapies.
• Further research into these pathways will advance rational drug design for cancer treatment.